Key requirements
Specified medical and therapeutic products, including qualifying Class 2 cell, tissue or gene-therapy products from December 2021, can receive import relief for regulated local trials, overseas-trial re-export or destruction. Follow Customs scope and application requirements rather than assume every laboratory material qualifies. API contract manufacturers can assess ACMT, with other biomedical segments considered case by case. That scheme addresses qualifying overseas-client value-added work and consigned goods, not an automatic zero-rating for all research services. Research grants and services require the separate biomedical guide’s analysis of consideration, customer and direct benefit.
Official source
A concise, independent Apex Gateway guide based on the official English source, not a reproduction of the complete document. Consult the original for full conditions, exceptions and subsequent updates.
Read the official source ↗